Peter A. Campochiaro

Author

Also Known As

Campochiaro, P.A., Campochiaro, Peter A., Donald J. Zack, Kachi, Shu, Miguel Busquets, N Rajagopalan, P A Campochiaro, P Campochiaro, P. A. Campochiaro, P. CAMPOCHIARO

541

Publications

41.7K

Citations

111

H-Index

177

Concepts

All Affiliations

Johns Hopkins University Johns Hopkins Medicine University of Virginia Retina Consultants of Texas

About

Peter A. Campochiaro is an author at Johns Hopkins University specializing in medicine, ophthalmology, and vascular biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	79	162	21.8K
2	Health Sciences	11	12	1.6K
3	Natural Sciences	10	10	745
4	Public Health	5	5	2.5K
5	Engineering	3	3	209

Peter A. Campochiaro

300

Publications

37.3K

Citations

105

H-Index

Page 1

	Year	Citations
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants Lars G. Fritsche, Wilmar Igl, Jessica N. Cooke Bailey, Nature Genetics Genome-wide Association StudyOcular DiseaseOphthalmologyGeneticsAge-related Diseases	2015	1.6K
Ranibizumab for Macular Edema following Central Retinal Vein Occlusion David M. Brown, Peter A. Campochiaro, Rishi P. Singh, Ophthalmology Ocular DiseaseMacular EdemaOphthalmology	2010	1.1K
Angiopoietin-2 Is Required for Postnatal Angiogenesis and Lymphatic Patterning, and Only the Latter Role Is Rescued by Angiopoietin-1 Nicholas W. Gale, Gavin Thurston, Sean F. Hackett, Developmental Cell TransplantationDevelopmental BiologyAngiogenesisLatter Role IsMedicine	2002	1K
Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion Peter A. Campochiaro, Jeffrey S. Heier, Leonard Feiner, Ophthalmology Ocular DiseaseMacular EdemaOphthalmology	2010	798
Seven new loci associated with age-related macular degeneration Lars G. Fritsche, Wei Chen, Matthew Schu, Nature Genetics Ocular DiseaseOphthalmologyAge-related DiseasesPathologyNew Loci	2013	790
Sustained Benefits from Ranibizumab for Macular Edema following Central Retinal Vein Occlusion: Twelve-Month Outcomes of a Phase III Study Peter A. Campochiaro, David M. Brown, Carl C. Awh, Ophthalmology Macular EdemaOcular DiseaseVitreous BodyOphthalmologySurgery	2011	698
Cell Type–Specific Regulation of Angiogenic Growth Factor Gene Expression and Induction of Angiogenesis in Nonischemic Tissue by a Constitutively Active Form of Hypoxia-Inducible Factor 1 Brian Kelly, Sean F. Hackett, Kiichi Hirota, Circulation Research AngiogenesisStem CellsCell Type–specific RegulationHealth SciencesMolecular Signaling	2003	603
Two-Year Outcomes of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) Study Quan Dong Nguyen, Syed Mahmood Shah, Afsheen Khwaja, Ophthalmology Metabolic SyndromeDiabetes ManagementDiabetesTwo-year OutcomesDiabetes Mellitus	2010	529
Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration Wei Chen, Dwight Stambolian, Albert O. Edwards, Proceedings of the National Academy of Sciences	2010	511
Sustained Delivery Fluocinolone Acetonide Vitreous Inserts Provide Benefit for at Least 3 Years in Patients with Diabetic Macular Edema Peter A. Campochiaro, David M. Brown, Andrew Pearson, Ophthalmology Ocular DiseaseVitreous BodyOphthalmologySurgeryLeast 3	2012	493

Page 1